TN2014000413A1 - Anti-baff-anti-il-17 bispecific antibodies - Google Patents

Anti-baff-anti-il-17 bispecific antibodies

Info

Publication number
TN2014000413A1
TN2014000413A1 TNP2014000413A TN2014000413A TN2014000413A1 TN 2014000413 A1 TN2014000413 A1 TN 2014000413A1 TN P2014000413 A TNP2014000413 A TN P2014000413A TN 2014000413 A TN2014000413 A TN 2014000413A TN 2014000413 A1 TN2014000413 A1 TN 2014000413A1
Authority
TN
Tunisia
Prior art keywords
baff
bispecific antibodies
sle
pss
psoriasis
Prior art date
Application number
TNP2014000413A
Other languages
French (fr)
Inventor
Barrett Allan
Robert Jan Benschop
Jirong Lu
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2013/036677 external-priority patent/WO2013158577A1/en
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of TN2014000413A1 publication Critical patent/TN2014000413A1/en

Links

Abstract

Bispecific antibodies are provided that specifically bind B-cell Activating Factor of the TNF Family (BAFF) and Interleukin-17A (IL-17) and are characterized as having high affinity and strong neutralizing properties to both BAFF and IL-17. The bispecific antibodies of the invention are expected to be useful in treating Lupus Nephritis (LN), Systemic Lupus Erythematosus (SLE), Rheumatoid Arthritis (RA), Psoriasis (Ps), Ankylosing Spondylitis (AS), Psoriatic Arthritis (PA), primary Sjögren's Syndrome (pSS), or Multiple Myeloma (MM).
TNP2014000413A 2013-02-25 2014-09-30 Anti-baff-anti-il-17 bispecific antibodies TN2014000413A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361768747P 2013-02-25 2013-02-25
PCT/US2013/036677 WO2013158577A1 (en) 2012-04-20 2013-04-16 Anti-baff-anti-il-17 bispecific antibodies

Publications (1)

Publication Number Publication Date
TN2014000413A1 true TN2014000413A1 (en) 2015-12-21

Family

ID=55447262

Family Applications (1)

Application Number Title Priority Date Filing Date
TNP2014000413A TN2014000413A1 (en) 2013-02-25 2014-09-30 Anti-baff-anti-il-17 bispecific antibodies

Country Status (1)

Country Link
TN (1) TN2014000413A1 (en)

Similar Documents

Publication Publication Date Title
PH12014502333A1 (en) Anti-baff-anti-il-17 bispecific antibodies
MX2015011957A (en) Anti-tnf-anti-il-17 bispecific antibodies.
PH12015501994A1 (en) Antibodies that bind il-23
PH12018502225A1 (en) Anti-il-33 antibodies, compositions, methods and uses thereof
MX2022009875A (en) Anti-variant fc-region antibodies and methods of use.
NZ739252A (en) Monoclonal antibodies against bcma
PH12015501656B1 (en) Anti-il-33 antibodies and use thereof
WO2014152157A3 (en) Methods and compositions for the generation and use of conformation-specific antibodies
TN2017000352A1 (en) Antibodies to tau and uses thereof
MX2016006101A (en) Il-17a conjugate and uses thereof.
WO2015013389A3 (en) Anti-galectin-1 (gal1) monoclonal antibodies and fragments thereof for neutralizing gal1
MX2018013072A (en) Tl1a antibodies and uses thereof.
EP3573658A4 (en) Anti-tnf antibodies, compositions, and methods for the treatment of active psoriatic arthritis
EA201491471A1 (en) COMPOSITION CONTAINING ANTIBODY AGAINST IL-17
EP4023674A3 (en) Anti-il-22r antibodies
MY174711A (en) Novel anti-fc-gamma receptor iib antibodies and uses thereof
TN2014000413A1 (en) Anti-baff-anti-il-17 bispecific antibodies
TH1401006266A (en) ANTI-BAFF-ANTI-IL-17 Bspecific Antibody
WO2014113431A3 (en) Methods and compositions for targeting immunoglobulins
UA113080C2 (en) A SPECIFIC ANTIBODY THAT SPECIFICALLY Binds to IL17 AND BAFF